HIGHLIGHTS
- who: Narimane Nekkab from the Allschwil, Switzerland University have published the research: Accelerated development of malaria monoclonal antibodies, in the Journal: (JOURNAL) of October/18,/2022
SUMMARY
Spotlight provided in the second season after a single administration; however, meeting the volume needs would be challenging since elimination requires both child and adult populations to be targeted by prevention tools. Trials conducted in perennial settings with longer follow-up times into the second year will be essential to understanding whether L9LS or other mAbs can achieve such extended protection. While it is hoped anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.